Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
| Division | Study Number | Title Sort descending | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0068 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) | Madhukar H. Trivedi, M.D. | Oct 07, 2022 |
| CTN | NIDA-CTN-0054 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) | Walter Ling, M.D. | Oct 09, 2020 |
| CTN | NIDA-CTN-0053 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) | Kevin M. Gray, MD | Jul 13, 2018 |
| CTN | NIDA-CTN-0031A | An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | Nov 26, 2013 |
| DTMC | NIDA-MDS-0002 | Assessment of Interactions Between Methamphetamine and Aripiprazole | Thomas F. Newton, M.D. | May 07, 2018 |
| DTMC | NIDA-CPU-0010 | Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine | Louis Cantilena, Jr., M.D, Ph.D. | Jun 03, 2020 |
| DTMC | NIDA-CTO-0003 | Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0004 | Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0010 | Assessment of Potential Interactions Between Methamphetamine and Bupropion | Thomas F. Newton, M.D. | May 07, 2018 |
| CTN | NIDA-CTN-0008 | Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation | Dennis McCarty, Ph.D. | Jan 25, 2007 |